San Jose, CA, July 06, 2017 -- Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skin care and aesthetic solutions, announced the launch of a new unique anti-aging lip treatment – Hyla3D HA Lip Complex. Experience fuller, more defined and youthful looking lips and soften the appearance of vertical lip lines with Hyla3D HA Lip Complex.
|
||||||
Hyla3D HA Lip Complex uniquely combats the visible signs of aging of the lip and surrounding skin. Multiple advanced forms of Hyaluronic Acid hydrate the skin, advanced peptides help enhance volume and firmness for improved definition and contour, and retinol and DMAE work together to soften and reduce the appearance of fine lines and wrinkles around the lips.
Jan Marini, CEO of Jan Marini Skin Research states, “Lips are a key facial focal point. The lip and peri-oral area has unique aging challenges. Hyla3D HA Lip Complex is a dynamic breakthrough in managing the aging lip area, by providing significant improvement in the appearance of volume, definition and vertical lip lines.”
Hyla3D HA Lip Complex joins Hyla3D HA Activating Complex as two new products in Jan Marini Skin Research’s advanced new Hyaluronic Acid line, Hyla3D, focused on advanced technologies top Apply, Enhance and Boost Hyaluronic acid in the skin. Hyla3D HA Lip Complex began shipping on June 19, 2017 and is available through authorized professional JMSR resellers and via the company’s website at www.janmarini.com.
About Jan Marini Skin Research, Inc.
A San Jose, CA. based company founded in 1994, Jan Marini Skin Research, Inc. is a recognized leader and innovator in the professionally dispensed skin care market segment. With multiple peer-reviewed published solutions and numerous industry innovations over the past 23 years, including the patented ingredient Thymosin Beta-4 and the first topical lipid-soluble Vitamin C product introduced to the market, JMSR’s two primary focuses are to provide innovated technologies that deliver proven measurable results and an unwavering commitment to the ongoing success of our customers.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2afd97f8-88ea-4af1-b5ab-8c5d50099775
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/db997797-c5e6-43c0-9b42-c9f4177a44b5
Kim Conley Jan Marini Skin Research 408-620-3611 [email protected]


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
First Western Ship Transits Strait of Hormuz Since Iran War Began
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Apple Turns 50: From Garage Startup to AI Crossroads
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



